Phase I Trial of a Combination of the Multikinase Inhibitor Sorafenib and the Farnesyltransferase Inhibitor Tipifarnib in Advanced Malignancies

Title
Phase I Trial of a Combination of the Multikinase Inhibitor Sorafenib and the Farnesyltransferase Inhibitor Tipifarnib in Advanced Malignancies
Authors
Keywords
-
Journal
CLINICAL CANCER RESEARCH
Volume 15, Issue 22, Pages 7061-7068
Publisher
American Association for Cancer Research (AACR)
Online
2009-11-11
DOI
10.1158/1078-0432.ccr-09-1241

Ask authors/readers for more resources

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started